Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan Nasal Spray For Frequent Nighttime Urination Faces Review Hurdles

Oct 18 2016

• By Brenda Sandburg

Related Content

Allergan Buys Global Rights To Serenity's Phase III Drug For Frequent Nighttime Urination

Apr 02 2010

Ferring’s Nocdurna Nixed By FDA Panel, But Gets Multiple Paths Forward

Jan 13 2015

Related Companies

Serenity Pharmaceuticals LLC

Allergan plc

Ferring Pharmaceuticals

Additional Topics

United States Advisory Committees Drug Review Drug Approval Standards Regulation BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window